These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 22283858)

  • 1. Abnormal finding on a screening endomyocardial biopsy.
    Stehlik J; Labedi M; Miller D; Revelo MP
    Am J Transplant; 2012 Feb; 12(2):500; quiz 499, 501. PubMed ID: 22283858
    [No Abstract]   [Full Text] [Related]  

  • 2. Magnetic resonance imaging in cardiac amyloidosis.
    Pennell DJ; Maceira AM
    JACC Cardiovasc Imaging; 2009 Dec; 2(12):1378-80. PubMed ID: 20083071
    [No Abstract]   [Full Text] [Related]  

  • 3. The role of echocardiography and 99mTc-HDP scintigraphy in non-invasive diagnosis of cardiac amyloidosis: A case series and literature review.
    Costache II; Buburuz AM; Crisu D; Statescu AM; Ungureanu C; Aursulesei V
    Medicine (Baltimore); 2019 Sep; 98(38):e17256. PubMed ID: 31567998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Echocardiographic and electrocardiographic presentations of patients with endomyocardial biopsy-proven cardiac amyloidosis.
    Roslan A; Kamsani SH; Nay TW; Tan KL; Hakim N; Tan AM; Megat Samsudim WN; Tan KL; Jauhari AT; Krishnan M; Leong D; Supramaniam T; Tan LK; Nuruddin AA
    Med J Malaysia; 2018 Dec; 73(6):388-392. PubMed ID: 30647209
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of cardiac biopsy in the diagnosis and management of cardiac disease.
    Fowles RE; Mason JW
    Prog Cardiovasc Dis; 1984; 27(3):153-72. PubMed ID: 6436904
    [No Abstract]   [Full Text] [Related]  

  • 6. Delayed hyper-enhancement magnetic resonance imaging provides incremental diagnostic and prognostic utility in suspected cardiac amyloidosis.
    Austin BA; Tang WH; Rodriguez ER; Tan C; Flamm SD; Taylor DO; Starling RC; Desai MY
    JACC Cardiovasc Imaging; 2009 Dec; 2(12):1369-77. PubMed ID: 20083070
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The Changing Appearance of Cardiac Amyloidosis].
    Mahrholdt H; Klingel K; Sechtem U
    Dtsch Med Wochenschr; 2018 Sep; 143(18):1335-1343. PubMed ID: 30199915
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Echocardiographic and pathologic findings of wild-type transthyretin senile systemic amyloidosis developed in early 50s.
    Yoshioka G; Watanabe N; Koita H; Asada Y; Ashikaga K; Kuriyama N; Shibata Y
    J Echocardiogr; 2018 Dec; 16(4):187-188. PubMed ID: 29700757
    [No Abstract]   [Full Text] [Related]  

  • 9. Impact of clinical and echocardiographic characteristics on occurrence of cardiac events in cardiac amyloidosis as proven by endomyocardial biopsy.
    Nakahashi T; Arita T; Yamaji K; Inoue K; Yokota T; Hoshii Y; Fukunaga M; Nomura A; Watanabe H; Miura S; Isotani A; Soga Y; Ando K; Iwabuchi M; Yokoi H; Nosaka H; Yamagishi M; Nobuyoshi M
    Int J Cardiol; 2014 Oct; 176(3):753-9. PubMed ID: 25131905
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endomyocardial biopsy: a review of the literature.
    Przybojewski JZ
    Cathet Cardiovasc Diagn; 1985; 11(3):287-330. PubMed ID: 3893740
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnosis of cardiac amyloidosis by myocardial biopsy.
    Hedner P; Rausing A; Steen K; Torp A
    Acta Med Scand; 1975 Dec; 198(6):525-8. PubMed ID: 1211220
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiac amyloidosis: typical imaging findings and diffuse myocardial damage demonstrated by delayed contrast-enhanced MRI.
    Sueyoshi E; Sakamoto I; Okimoto T; Hayashi K; Tanaka K; Toda G
    Cardiovasc Intervent Radiol; 2006; 29(4):710-2. PubMed ID: 16565801
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiac amyloidosis. Diagnosis by transvenous endomyocardial biopsy.
    Schroeder JS; Billingham ME; Rider AK
    Am J Med; 1975 Aug; 59(2):269-73. PubMed ID: 1098458
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myocardial contrast echocardiography in biopsy-proven primary cardiac amyloidosis.
    Abdelmoneim SS; Bernier M; Bellavia D; Syed IS; Mankad SV; Chandrasekaran K; Pellikka PA; Mulvagh SL
    Eur J Echocardiogr; 2008 Mar; 9(2):338-41. PubMed ID: 18490333
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary cardiac amyloidosis: A review of the literature.
    Przybojewski JZ; Daniels AR; Van der Walt JJ
    S Afr Med J; 1980 May; 57(20):831-7. PubMed ID: 6996129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiac amyloidosis: the importance of a multidisciplinary approach.
    Gómez-Bueno M; Segovia J; García-Pavía P; Barceló JM; Krsnik I; Sánchez-Turrión V; Salas C; Alonso-Pulpón L
    Rev Esp Cardiol; 2009 Jun; 62(6):698-702. PubMed ID: 19480768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety of transvenous right ventricular endomyocardial biopsy guided by two-dimensional echocardiography.
    Blomström-Lundqvist C; Noor AM; Eskilsson J; Persson S
    Clin Cardiol; 1993 Jun; 16(6):487-92. PubMed ID: 8358882
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Syncope from dynamic left ventricular outflow tract obstruction simulating hypertrophic cardiomyopathy in a patient with primary AL-type amyloid heart disease.
    Velazquez-Ceceña JL; Lubell DL; Nagajothi N; Al-Masri H; Siddiqui M; Khosla S
    Tex Heart Inst J; 2009; 36(1):50-4. PubMed ID: 19436787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemotherapy-associated nonbacterial thrombotic endocarditis: A radiological mimicker of cardiac amyloidosis requiring histopathologic examination for definitive diagnosis.
    Sekulic M; Gupta A; Patterson A; Oliveira G; Rajagopalan S
    Cardiovasc Pathol; 2020; 47():107210. PubMed ID: 32142924
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent advances in the noninvasive strategies of cardiac amyloidosis.
    Zhao L; Fang Q
    Heart Fail Rev; 2016 Nov; 21(6):703-721. PubMed ID: 27554493
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.